Tassos Gianakakos
2018
In 2018, Tassos Gianakakos earned a total compensation of $9M as President, Chief Executive Officer and Director at MyoKardia, a 180% increase compared to previous year.
Compensation breakdown
| Bonus | $43,250 |
|---|---|
| Non-Equity Incentive Plan | $396,750 |
| Option Awards | $6,373,376 |
| Salary | $569,204 |
| Stock Awards | $1,591,200 |
| Other | $1,000 |
| Total | $8,974,780 |
Gianakakos received $6.4M in option awards, accounting for 71% of the total pay in 2018.
Gianakakos also received $43.3K in bonus, $396.8K in non-equity incentive plan, $569.2K in salary, $1.6M in stock awards and $1K in other compensation.
Rankings
In 2018, Tassos Gianakakos' compensation ranked 840th out of 14,244 executives tracked by ExecPay. In other words, Gianakakos earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 840 out of 14,244 | 94th |
Division Manufacturing | 283 out of 5,765 | 95th |
Major group Chemicals And Allied Products | 85 out of 2,128 | 96th |
Industry group Drugs | 67 out of 1,817 | 96th |
Industry Pharmaceutical Preparations | 46 out of 1,391 | 97th |
Source: SEC filing on April 24, 2019.
Gianakakos' colleagues
We found five more compensation records of executives who worked with Tassos Gianakakos at MyoKardia in 2018.